Meeder Asset Management Inc Sarepta Therapeutics, Inc. Transaction History

Meeder Asset Management Inc

$1.47 Billion
Q1 2025

A detailed history of Meeder Asset Management Inc transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Meeder Asset Management Inc holds 26 shares of SRPT stock, worth $1,015. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Previous 32 18.75%

Holding current value

$1,015

Previous $3,000 66.67%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 07, 2025	SELL	$63.82 - $127.89 $382 - $767	-6 Reduced 18.75%	26 $1,000
Q4 2024 Feb 12, 2025	SELL	$104.54 - $137.94 $53,733 - $70,901	-514 Reduced 94.14%	32 $3,000
Q3 2024 Nov 07, 2024	BUY	$124.33 - $156.75 $2,610 - $3,291	21 Added 4.0%	546 $68,000
Q2 2024 Aug 08, 2024	BUY	$113.33 - $163.85 $55,758 - $80,614	492 Added 1490.91%	525 $82,000
Q1 2024 May 07, 2024	BUY	$93.7 - $141.53 $3,092 - $4,670	33 New	33 $4,000
Q2 2022 Aug 08, 2022	SELL	$62.69 - $88.44 $1,379 - $1,945	-22 Reduced 84.62%	4 $0
Q1 2022 May 10, 2022	BUY	$63.15 - $90.42 $1,641 - $2,350	26 New	26 $2,000
Q4 2021 Feb 11, 2022	SELL	$77.28 - $99.42 $1,081 - $1,391	-14 Closed	0 $0
Q3 2021 Nov 08, 2021	SELL	$65.97 - $92.48 $263 - $369	-4 Reduced 22.22%	14 $1,000
Q2 2021 Aug 09, 2021	SELL	$69.38 - $86.75 $69 - $86	-1 Reduced 5.26%	18 $1,000
Q1 2021 Apr 28, 2021	SELL	$72.25 - $168.95 $1,228 - $2,872	-17 Reduced 47.22%	19 $1,000
Q4 2020 Feb 09, 2021	BUY	$125.56 - $178.74 $125 - $178	1 Added 2.86%	36 $6,000
Q3 2020 Nov 02, 2020	SELL	$127.12 - $172.34 $889 - $1,206	-7 Reduced 16.67%	35 $5,000
Q2 2020 Aug 11, 2020	SELL	$93.0 - $171.7 $2,325 - $4,292	-25 Reduced 37.31%	42 $7,000
Q1 2020 May 15, 2020	SELL	$82.38 - $131.64 $411 - $658	-5 Reduced 6.94%	67 $7,000
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $3,443 - $6,101	45 Added 166.67%	72 $9,000
Q3 2019 Oct 17, 2019	SELL	$72.81 - $156.91 $14,707 - $31,695	-202 Reduced 88.21%	27 $2,000
Q2 2019 Aug 05, 2019	SELL	$112.21 - $151.95 $558,805 - $756,711	-4,980 Reduced 95.6%	229 $35,000
Q1 2019 Apr 16, 2019	BUY	$106.67 - $151.68 $282,035 - $401,041	2,644 Added 103.08%	5,209 $620,000
Q4 2018 Jan 17, 2019	BUY	$97.32 - $148.76 $235,125 - $359,404	2,416 Added 1621.48%	2,565 $281,000
Q3 2018 Nov 02, 2018	SELL	$115.31 - $161.51 $31,364 - $43,930	-272 Reduced 64.61%	149 $0
Q2 2018 Jul 24, 2018	BUY	$71.74 - $153.69 $30,202 - $64,703	421 New	421 $0
Q1 2018 May 03, 2018	SELL	$54.02 - $82.27 $1,620 - $2,468	-30 Closed	0 $0
Q4 2017 Feb 02, 2018	SELL	$47.64 - $56.75 $2,096 - $2,497	-44 Reduced 59.46%	30 $2,000
Q3 2017 Oct 20, 2017	BUY	$35.73 - $47.15 $2,644 - $3,489	74	74 $3,000

Others Institutions Holding SRPT

# of Institutions

508

Shares Held

88.9M

Call Options Held

1.39M

Put Options Held

1.13M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $3.42B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Meeder Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Meeder Asset Management Inc with notifications on news.

Account

Meeder Asset Management Inc Sarepta Therapeutics, Inc. Transaction History